We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
869
Increased
2,214
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.37%
2 Healthcare 7.45%
3 Consumer Discretionary 5.14%
4 Industrials 5.1%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEVS
6726
DELISTED
DevvStream Corp
DEVS
-49,000
Closed -$5.1M
ABP
6727
DELISTED
Abpro Holdings
ABP
-9,277
Closed -$2.89M
SUNE
6728
SUNation Energy
SUNE
$8.86M
0
-$18K
ENFY
6729
DELISTED
Enlightify Inc
ENFY
-12,477
Closed -$51K
MTVA
6730
MetaVia Inc
MTVA
$7.39M
-132
Closed -$8K
PVLA
6731
Palvella Therapeutics
PVLA
$2.05B
-998
Closed -$78K
ASBP
6732
Aspire Biopharma
ASBP
$9.39M
-458
Closed -$5.78M
WHWK
6733
Whitehawk Therapeutics
WHWK
$182M
-72,375
Closed -$524K
SPWRW
6734
CALL
SunPower Inc Warrants
SPWRW
$596K
-134,110
Closed -$34K
WMPN
6735
DELISTED
William Penn Bancorporation Common Stock
WMPN
-29,102
Closed -$330K
YOTA
6736
DELISTED
Yotta Acquisition Corporation Common Stock
YOTA
-100,000
Closed -$1.03M
OCEA
6737
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
-28,493
Closed -$189K
ENZ
6738
DELISTED
Enzo Biochem, Inc.
ENZ
-70,685
Closed -$172K
PEV
6739
DELISTED
Phoenix Motor Inc. Common Stock
PEV
-14,571
Closed -$9K
NXU
6740
DELISTED
Nxu, Inc. Class A Common Stock
NXU
-4
Closed -$7K
ITCI
6741
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-20,000
Closed -$1.08M
VOXX
6742
DELISTED
VOXX International Corporation Class A
VOXX
-164,740
Closed -$2.03M
PLAO
6743
DELISTED
Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares
PLAO
-250,000
Closed -$2.63M
VMCA
6744
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
-360,000
Closed -$3.79M
PNST
6745
DELISTED
Pinstripes Holdings, Inc.
PNST
-200,000
Closed -$2.08M
NKGN
6746
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
-153,494
Closed -$1.55M
RFAC
6747
DELISTED
RF Acquisition Corp. Class A Common Stock
RFAC
-30,000
Closed -$309K
ALCE
6748
DELISTED
Alternus Clean Energy Inc
ALCE
-16,000
Closed -$4.1M
CDMO
6749
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-60,659
Closed -$1.14M
AE
6750
DELISTED
Adams Resources & Energy Inc
AE
-8,402
Closed -$323K

Similar funds

Millennium Management's Q2 2023 Portfolio in Review

As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
  • Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.